Genus PLC (GNS)

Currency in GBP
2,915.0
+75.0(+2.64%)
Closed·
GNS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,850.02,970.0
52 wk Range
1,548.03,220.0
Key Statistics
Bid/Ask
2,900.00 / 2,930.00
Prev. Close
2,840
Open
2,850
Day's Range
2,850-2,970
52 wk Range
1,548-3,220
Volume
251.33K
Average Volume (3m)
176.73K
1-Year Change
66.5714%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GNS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3,166.7
Upside
+8.63%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Genus PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Genus PLC Company Profile

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Genus PLC Earnings Call Summary for H1/2026

  • Genus PLC reported 57% profit before tax increase to £55.7M and 53% EPS growth to 60.8p, despite flat revenue in H1 FY2026.
  • Stock declined 7.89% in early trading amid investor concerns over operational challenges and market conditions.
  • PRRS-resistant pig technology received Canadian regulatory approval; awaiting clearance in Mexico and Japan for commercialization.
  • Company forecasts stronger H2 free cash flow, targeting 70% cash conversion and full-year FCF exceeding FY2025 levels.
  • Interim dividend raised to 11.2p from 10.3p; challenges include weak Chinese pork prices and U.S. bovine genetics border closure.
Last Updated: 26/02/2026, 10:54
Read Full Transcript

Compare GNS to Peers and Sector

Metrics to compare
GNS
Peers
Sector
Relationship
P/E Ratio
40.9x−6.6x−0.6x
PEG Ratio
0.03−0.070.00
Price/Book
3.9x3.7x2.6x
Price / LTM Sales
2.9x5.7x3.3x
Upside (Analyst Target)
13.2%131.3%44.8%
Fair Value Upside
Unlock0.5%5.5%Unlock

Analyst Ratings

7 Buy
2 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3,166.7
(+8.63% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Berenberg
Buy33.50+14.92%32.50MaintainJan 27, 2026
Deutsche Bank
Buy33.00+13.21%31.00MaintainJan 19, 2026
Investec
Buy30.21+3.64%29.65MaintainJan 18, 2026
Berenberg
Buy30.50+4.63%-New CoverageNov 26, 2025
Deutsche Bank
Buy31.00+6.35%29.00MaintainNov 20, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.72%
Dividend Yield
1.10%
Industry Median 1.06%
Annualised payout
32.00
Paid unevenly
5-Years Growth
+1.86%
Growth Streak

Earnings

Latest Release
Feb 26, 2026
EPS / Forecast
0.60 / --
Revenue / Forecast
335.60M / --
EPS Revisions
Last 90 days

GNS Income Statement

People Also Watch

267.80
EMG
+1.13%
405.70
HLN
+2.92%
1,267.00
BEZG
+1.69%
4,268.00
ANTO
+0.19%
253.40
HBR
+3.94%

FAQ

What Is the Genus (GNS) Stock Price Today?

The Genus stock price today is 2,915.0 GBP.

What Stock Exchange Does Genus Trade On?

Genus is listed and trades on the London Stock Exchange.

What Is the Stock Symbol for Genus?

The stock symbol for Genus is "GNS."

What Is the Genus Market Cap?

As of today, Genus market cap is 1.95B GBP.

What Is Genus's Earnings Per Share (TTM)?

The Genus EPS (TTM) is 0.7.

When Is the Next Genus Earnings Date?

Genus will release its next earnings report on Feb 26, 2026.

From a Technical Analysis Perspective, Is GNS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Genus Stock Split?

Genus has split 0 times.

How Many Employees Does Genus Have?

Genus has 3190 employees.

What is the current trading status of Genus (GNS)?

As of Feb 28, 2026, Genus (GNS) is trading at a price of 2,915.0 GBP, with a previous close of 2,840.0 GBP. The stock has fluctuated within a day range of 2,850.0 GBP to 2,970.0 GBP, while its 52-week range spans from 1,548.0 GBP to 3,220.0 GBP.

What Is Genus (GNS) Price Target According to Analysts?

The average 12-month price target for Genus is 3,166.7 GBP, with a high estimate of 3700 GBP and a low estimate of 2550 GBP. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +8.63% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.